Independent analysis puts a HJ dulaglutide lot at 98.7%, against 96.2% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 20 of 48 of this archive, newest first.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
The purity figure is the least informative line on a well-constructed certificate and the only line most buyers read.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Follow the resin, not the catalogue.
Every step between the laboratory report and the product page removes information, and the badge is the last step.
Follow the resin, not the catalogue.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
A reminder that a purity figure is the output of a method, and that methods differ.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Follow the resin, not the catalogue.
The supplier has not disputed the finding. It has not explained the gap either.
The result is unremarkable. What the report omits is not.
The route did not close because of a rule about peptides.
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.